首页> 美国卫生研究院文献>other >Synergistic antibiofilm efficacy of a gallotannin 126-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms
【2h】

Synergistic antibiofilm efficacy of a gallotannin 126-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms

机译:Terminal子果实中的没食子素126-三-O-galloyl-β-D-吡喃葡萄糖与庆大霉素和甲氧苄氨嘧啶的协同抗生物膜功效对多药耐药性尿路致病性大肠杆菌生物膜的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years the emergence of multiple drug resistance microbes has become a global public health problem. The aim of the present investigation was to evaluate possible antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-β-D-glucopyranose from Terminalia chebula fruits alone and in combination with gentamicin and trimethoprim against preformed biofilms of multidrug-resistant (MDR) uropathogenic E. coli isolates using microbroth dilution, checkerboard titration and kill kinetics methods. Test gallotannin showed > 50% antibiofilm efficacy after 24 h when administered alone whereas gentamicin and trimethoprim failed to do so. But in combination, test gallotannin/gentamicin and test gallotannin/trimethoprim showed 71.24±6.75% and 93.4±8.46% antibiofilm activity respectively. On the basis of FICI values, test gallotannin/gentamicin showed synergistic interactions against 71.42% and test gallotannin/trimethoprim against 85.71% biofilm forming test bacterial isolates. Kill-kinetics study confirmed their synergistic interactions. Thus, gentamicin and trimethoprim in combination with test gallotannin may have potential for treatment of urinary tract infections caused by biofilm forming MDR uropathogenic E. coli.
机译:近年来,多种耐药菌的出现已成为全球性的公共卫生问题。本研究的目的是评估单独来自终ia属果实和与庆大霉素和甲氧苄氨嘧啶联用的加洛太宁1,2,6-三-O-galloyl-β-D-吡喃葡萄糖的可能的抗生物膜功效对预先形成的多药生物膜的抗生物膜作用。抗性(MDR)尿路致病性大肠埃希菌分离物,采用微肉汤稀释,棋盘滴定和杀灭动力学方法。当单独施用时,测试单加仑宁显示24小时后抗生物膜功效> 50%,而庆大霉素和甲氧苄啶则没有。但组合起来,测试镓单宁/庆大霉素和测试镓单宁/甲氧苄氨嘧啶的抗生物膜活性分别为71.24±6.75%和93.4±8.46%。基于FICI值,测试没食子鞣质/庆大霉素对71.42%显示协同作用,测试没食子鞣质/甲氧苄啶对85.71%形成生物膜的测试细菌分离株具有协同作用。杀伤动力学研究证实了它们的协同作用。因此,庆大霉素和甲氧苄氨嘧啶与测试没食子单宁组合可能具有治疗由生物膜形成MDR尿路致病性大肠杆菌引起的尿路感染的潜力。

著录项

  • 期刊名称 other
  • 作者单位
  • 年(卷),期 -1(12),5
  • 年度 -1
  • 页码 e0178712
  • 总页数 11
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号